NitiDhamMD

Pediatric Echocardiography, Pediatric Heart Failure and Heart Transplantation

Associate Professor, Pediatrics, George Washington University Sch of Med and Health Sciences

Dr. Dham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
111 Michigan Ave Nw
Chilren's National Medical Center, Suite W3-200
Washington, DC 20010
Phone+1 202-476-2020

Fax+1 202-476-5700

Children's National Hospital/George Washington UniversityFellowship, Pediatric Cardiology, 2006 - 2008
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 2002 - 2005
St. George's University School of MedicineClass of 2002

PubMed

2 citations
Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy.
Cordula M Wolf, Martin Zenker, Olga Boleti, Gabrielle Norrish, Mark Russell
JACC. Basic to Translational Science. 2025-02-01
Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis.
Despoina Galetaki, Anqing Zhang, Yulan Qi, Nadia Merchant, Roopa Kanakatti Shankar
Hormone Research in Paediatrics. 2024-10-18
1 citations
Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.
Andrew Dauber, Anqing Zhang, Roopa Kanakatti Shankar, Kimberly Boucher, Tara McCarthy
Eclinicalmedicine. 2024-05-01

5 Things Doctors Want You to Know About Your Child’s HealthJune 17th, 2021
First Global Clinical Trial Achieves Promising Results for HypochondroplasiaMarch 15th, 2024